Oriola as an Investment

Oriola is a Finnish listed company. Oriola helps consumers to improve their wellbeing. In its own pharmacies, Oriola offers expert advice on health and wellbeing and an extensive and high-quality selection of products. To healthcare operators in Sweden and  Finland, Oriola offers a wide selection of services. Oriola unites consumers and pharmaceutical companies in a unique way. Oriola provides pharmaceutical companies an effective access to markets and improves consumers’ wellbeing by ensuring that pharmaceuticals, health products and services are delivered in a safe and customer-friendly manner.

Oriola has long experience and a strong position on the Finnish and Swedish pharmaceutical markets. In the Finnish pharmaceutical wholesale business, Oriola has a market share of approximately 46%, while in Sweden the share is approximately 44% in the pharmaceutical wholesale business and share of Swedish pharmacy market approximately 17%.

Oriola Corporation is listed on Nasdaq Helsinki. Oriola´s net sales were approximately EUR 1.7 billion in 2019. Company had approximately 2,800 employees (FTE) at the end of 2019.